IL33 and cancer: Poorer survival outcomes in HNSCC are linked to elevated ST2 expression in Tregs combined with the existence of IL-33-expressing CAFs.<h4>Conclusion</h4>CAF-driven cancer invasiveness relies on IL-33 signaling via paracrine and autocrine pathways.